NorthWest Biotherapeutics Inc (NWBO)

[skitahoe]

I care about approvals too, but I don't believe they'll happen prior to the Street learning what we have here. When the Street wakes up to NWBO we'll see tremendous profits. I believe that just the notice that MHRA has accepted a submission from us will be big, with or without a Journal, the Street will at least become aware of what's happening here.

I've never been in a company where less was known about what was happening just prior to regulatory filings. I cannot tell you if we're only approaching just the U.K., or if filings are being made with two, three, or all four regulators simultaneously. Certainly we've been far more open about what we're doing with the U.K., but it doesn't mean the others have been left out, or are more than a matter of a few weeks, or months behind.

I can't say the company was right, or wrong, insisting on a Journal article prior to ending their quiet period. Certainly, they could have had Dr. Liau present the data at a major technical conference ages ago. I'm not speaking of the data that's been presented, I'm speaking of all the data, not just what's permitted by the embargo they agreed to. Can anyone tell me how many of the current survivors are deemed to be cancer free, don't you think that's part of what would be included if we had all the data. There are many other things we've never heard about that I believe would comprise what should be in a Journal, or an oral presentation of the entire trial. To date we've not seen a TLD statement, we've seen a partial TLD presentation, that's it. Don't equate one with the other.

Gary